The predictive role of circulating microparticles in patients with chronic heart failure

BBA Clinical

Volumn 3, Issue , 2015, Pages 18-24

  Berezin, Alexander E ^a   Kremzer, Alexander A ^a   Martovitskaya, Yulia V ^a   Samura, Tatyana A ^a   Berezina, Tatyana A ^b  

^a ZAPORIZHZHIA STATE MEDICAL UNIVERSITY   (Ukraine)

^b Vita Center   (Ukraine)

Author keywords

Cardiovascular outcomes; Chronic heart failure; Microparticles; Predictive value

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; COHORT ANALYSIS; CORONARY ARTERY; ECHOCARDIOGRAPHY; EVALUATION AND FOLLOW UP; FEMALE; FLOW CYTOMETRY; GLOMERULUS FILTRATION RATE; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; HUMAN TISSUE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEMBRANE MICROPARTICLE; MIDDLE AGED; PHENOTYPE; RISK ASSESSMENT; TISSUE DOPPLER IMAGING;

EID: 84916882856     PISSN: 22146474     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbacli.2014.11.006     Document Type: Article

References (39)

1. Lloyd-Jones D., Adams R.J., Brown T.M., Carnethon M., Ferguson T.B., Ford E., et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 2010, 121(7):e46-e215.
2. Santulli G. Epidemiology of cardiovascular disease in the 21st century: updated numbers and updated facts. JCvD 2013, 1(1):1-2.
3. Ehrlich J.R., Kaluzny M., Baumann S., Lehmann R., Hohnloser S.H. Biomarkers of structural remodelling and endothelial dysfunction for prediction of cardiovascular events or death in patients with atrial fibrillation. Clin. Res. Cardiol. 2011, 100(11):1029-1036.
4. Tschöpe C., Van Linthout S. New insights in (inter)cellular mechanisms by heart failure with preserved ejection fraction. Curr. Heart Fail. Rep. 2014, 11(4):436-444.
5. Maisel A. Biomonitoring and biomarker-guided therapy: the next step in heart failure and biomarker research. J. Am. Coll. Cardiol. 2011, 58(18):1890-1892.
6. Alba A.C., Agoritsas T., Jankowski M., Courvoisier D., Walter S.D., Guyatt G.H., Ross H.J. Risk prediction models for mortality in ambulatory patients with heart failure: a systematic review. Circ. Heart Fail. 2013, 6(5):881-889.
7. Oremus M., Don-Wauchope A., McKelvie R., Santaguida P.L., Hill S., Balion C., et al. BNP and NT-proBNP as prognostic markers in persons with chronic stable heart failure. Heart Fail. Rev. 2014, 19(4):471-505.
8. Carrasco-Sánchez F.J., Páez-Rubio M.I. Review of the prognostic value of galectin-3 in heart failure focusing on clinical utility of repeated testing. Mol. Diagn. Ther. 2014, 18(6):599-604.
9. Rajendiran K.S., Ananthanarayanan R.H., Satheesh S., Rajappa M. Elevated levels of serum sialic acid and high-sensitivity C-reactive protein: markers of systemic inflammation in patients with chronic heart failure. Br. J. Biomed. Sci. 2014, 71(1):29-32.
10. De Beradinis B., Januzzi J.L. Use of biomarkers to guide outpatient therapy of heart failure. Curr. Opin. Cardiol. 2012, 27(6):661-668.
11. Mause S.F., Weber C. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ. Res. 2010, 107:1047-1057.
12. Arraud N., Linares R., Tan S., Gounou C., Pasquet J.M., Mornet S., Brisson A.R. Extracellular vesicles from blood plasma: determination of their morphology, size, phenotype and concentration. J. Thromb. Haemost. 2014, 12(5):614-627.
13. Berezin A.E., Kremzer A.A., Samura T.A., Martovitskaya Yu.V. Circulating endothelial-derived apoptotic microparticles in the patients with ischemic symptomatic chronic heart failure: relevance of pro-inflammatory activation and outcomes. Int. Cardiovasc. Res. J. 2014, 8(3):116-123.
14. Pirro M., Schillaci G., Bagaglia F., Menecali C., Paltriccia R., Mannarino M.R., et al. Microparticles derived from endothelial progenitor cells in patients at different cardiovascular risk. Atherosclerosis 2008, 197(2):757-767.
15. Jimenez J.J., Jy W., Mauro L.M., Soderland C., Horstman L.L., Ahn Y.S. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb. Res. 2003, 109:175-180.
16. Charan Reddy K.V. Regulatory noncoding RNAs in cardiovascular disease: shedding light on 'dark matter'. JCvD 2014, ([in press] http://researchpub.org/journal/jcvd/number/early/47.pdf).
17. Wronska A., Kurkowska-Jastrzebska I., Santulli G. Application of microRNAs in diagnosis and treatment of cardiovascular disease. Acta Physiol. 2014, (in press). 10.1111/apha.12416.
18. Santulli G., Campanile A., Spinelli L., Assante di Panzillo E., Ciccarelli M., et al. G protein-coupled receptor kinase 2 in patients with acute myocardial infarction. Am. J. Cardiol. 2011, 107:1125-1130.
19. Santulli G. Adrenal signaling in heart failure: something more than a distant ship's smoke on the horizon. Hypertension 2014, 63(2):215-216.
20. Bluemke D.A., Achenbach S., Budoff M., Gerber T.C., Gersh B., Hillis L.D., et al. Noninvasive coronary artery imaging: magnetic resonance angiography and multidetector computed tomography angiography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention of the Council on Cardiovascular Radiology and Intervention, and the Councils on Clinical Cardiology and Cardiovascular Disease in the Young. Circulation 2008, 118:586-606.
21. Schiller N.B., Shah P.M., Crawford M., De Maria A., Devereux R., Feigenbaum H., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J. Am. Soc. Echocardiogr. 1989, 2:358-367.
22. Pellerin D., Sharma R., Elliott P., Veyrat C. Tissue Doppler, strain, and strain rate echocardiography for the assessment of left and right systolic ventricular function. Heart 2003, 89(90003):iii9-iii17.
23. Levey A.S., Stevens L.A., Schmid C.H., Zhang Y.L., Castro A.F., Feldman H.I., et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 2009, 150(9):604-612. for the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration).
24. Lacroix R., Judicone C., Mooberry M., Boucekine M., Key N.S., Dignat-George F. The ISTH SSC Workshop. Standardization of pre-analytical variables in plasma microparticle determination: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. J. Thromb. Haemost. 2013, (Epub ahead of print). 10.1111/jth.12207.
25. Orozco A.F., Lewis D.E. Flow cytometric analysis of circulating microparticles in plasma. Cytometry A 2010, 77(6):502-514.
26. Nomura S., Ozaki Y., Ikeda Y. Function and role of microparticles in various clinical settings. Thromb. Res. 2008, 123:8-23.
27. Leroyer A.S., Anfosso F., Lacroix R., Sabatier F., Simoncini S., Njock S.M., et al. Endothelial-derived microparticles: biological conveyors at the crossroad of inflammation, thrombosis and angiogenesis. Thromb. Haemost. 2010, 104:456-463.
28. Boulanger C.M., Leroyer A.S., Amabile N., Tedgui A. Circulating endothelial microparticles: a new marker of vascular injury. Ann. Cardiol. Angeiol. (Paris) 2008, 57:149-154.
29. Pérez-Casal M., Downey C., Cutillas-Moreno B., Zuzel M., Fukudome K., Toh C.H. Microparticle-associated endothelial protein C receptor and the induction of cytoprotective and anti-inflammatory effects. Haematologica 2009, 94:387-394.
30. Mezentsev A., Merks R.M., O'Riordan E., Chen J., Mendelev N., Goligorsky M.S., Brodsky S.V. Endothelial microparticles affect angiogenesis in vitro: role of oxidative stress. Am. J. Physiol. Heart Circ. Physiol. 2005, 289(3):H1106-H1114.
31. Sabatier F., Roux V., Anfosso F., Camoin L., Sampol J., Dignat-George F. Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity. Blood 2002, 99:3962-3970.
32. Morel O., Toti F., Freyssinet J.M. Markers of thrombotic disease: procoagulant microparticles. Ann. Pharm. Fr. 2007, 65(2):75-84.
33. Loyer X., Vion A.C., Tedgui A., Boulanger C.M. Microvesicles as cell-cell messengers in cardiovascular diseases. Circ. Res. 2014, 114(2):345-353.
34. VanWijk M.J., Van Bavel E., Sturk A., Nieuwland R. Microparticles in cardiovascular diseases. Cardiovasc. Res. 2003, 59(2):277-287.
35. Markiewicz M., Richard E., Marks N., Ludwicka-Bradley A. Impact of endothelial microparticles on coagulation, inflammation, and angiogenesis in age-related vascular diseases. J. Aging Res. 2013, 2013:734509.
36. Chironi G.N., Boulanger C.M., Simon A., Dignat-George F., Freyssinet J.M., Tedgui A. Endothelial microparticles in diseases. Cell Tissue Res. 2009, 335:143-151.
37. Montoro-García S., Shantsila E., Tapp L.D., López-Cuenca A., Romero A.I., Hernández-Romero D., et al. Small-size circulating microparticles in acute coronary syndromes: relevance to fibrinolytic status, reparative markers and outcomes. Atherosclerosis 2013, 227(2):313-322.
38. Matsuzawa Y., Sugiyama S., Sumida H., Sugamura K., Nozaki T., Ohba K., et al. Peripheral endothelial function and cardiovascular events in high-risk patients. J. Am. Heart Assoc. 2013, 2(6):e000426.
39. Berezin A.E., Kremzer A.A., Samura T.A., Martovitskaya Y.V. Apoptotic microparticles to progenitor mononuclear cells ratio in heart failure: relevance of clinical status and outcomes. JCvD 2014, 2(2):50-57.